[SYRE] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Dec-2020
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -25.96%
YoY- -5.67%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 1,399 13,696 0 0 0 0 0 -
PBT -20,281 -6,738 -18,218 -22,714 -18,033 -21,418 -18,728 5.44%
Tax 26 92 0 0 0 0 0 -
NP -20,307 -6,830 -18,218 -22,714 -18,033 -21,418 -18,728 5.53%
Tax Rate - - - - - - - -
Total Cost 21,706 20,526 18,218 22,714 18,033 21,418 18,728 10.32%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -1,451.54 -49.87 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -7.72 -2.60 -6.94 0.00 -7.24 -10.11 -14.15 -33.20%
EPS Diluted -7.72 -2.60 -6.94 0.00 -7.24 -10.11 -14.15 -33.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.